MECOM and acute myeloid leukemia: Consequently, only four AML patients were classified under "AML with recurrent genetic abnormalities", including three patients with MECOM‐rearranged AML (inv(3)/t(3;3)), which was previously associated with IKZF1N159S mutations and adverse prognosis.10